vs

Side-by-side financial comparison of Bridger Aerospace Group Holdings, Inc. (BAER) and OCULAR THERAPEUTIX, INC (OCUL). Click either name above to swap in a different company.

OCULAR THERAPEUTIX, INC is the larger business by last-quarter revenue ($13.3M vs $8.5M, roughly 1.6× Bridger Aerospace Group Holdings, Inc.). Bridger Aerospace Group Holdings, Inc. runs the higher net margin — -177.2% vs -488.0%, a 310.7% gap on every dollar of revenue. On growth, OCULAR THERAPEUTIX, INC posted the faster year-over-year revenue change (-22.4% vs -45.2%). OCULAR THERAPEUTIX, INC produced more free cash flow last quarter ($-57.1M vs $-78.4M). Over the past eight quarters, Bridger Aerospace Group Holdings, Inc.'s revenue compounded faster (24.6% CAGR vs -5.3%).

Bridger Aerospace is an American aerospace company which provides aerial firefighting and wildfire management services. The company has supported firefighting efforts in 24 U.S. states and two Canadian provinces.

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

BAER vs OCUL — Head-to-Head

Bigger by revenue
OCUL
OCUL
1.6× larger
OCUL
$13.3M
$8.5M
BAER
Growing faster (revenue YoY)
OCUL
OCUL
+22.7% gap
OCUL
-22.4%
-45.2%
BAER
Higher net margin
BAER
BAER
310.7% more per $
BAER
-177.2%
-488.0%
OCUL
More free cash flow
OCUL
OCUL
$21.3M more FCF
OCUL
$-57.1M
$-78.4M
BAER
Faster 2-yr revenue CAGR
BAER
BAER
Annualised
BAER
24.6%
-5.3%
OCUL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BAER
BAER
OCUL
OCUL
Revenue
$8.5M
$13.3M
Net Profit
$-15.1M
$-64.7M
Gross Margin
-65.1%
88.0%
Operating Margin
-175.0%
-526.5%
Net Margin
-177.2%
-488.0%
Revenue YoY
-45.2%
-22.4%
Net Profit YoY
-17.9%
-33.6%
EPS (diluted)
$-0.26
$-0.27

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BAER
BAER
OCUL
OCUL
Q4 25
$8.5M
$13.3M
Q3 25
$67.9M
$14.5M
Q2 25
$30.8M
$13.5M
Q1 25
$15.6M
$10.7M
Q4 24
$15.6M
$17.1M
Q3 24
$64.5M
$15.4M
Q2 24
$13.0M
$16.4M
Q1 24
$5.5M
$14.8M
Net Profit
BAER
BAER
OCUL
OCUL
Q4 25
$-15.1M
$-64.7M
Q3 25
$34.5M
$-69.4M
Q2 25
$308.0K
$-67.8M
Q1 25
$-15.5M
$-64.1M
Q4 24
$-12.8M
$-48.4M
Q3 24
$27.3M
$-36.5M
Q2 24
$-10.0M
$-43.8M
Q1 24
$-20.1M
$-64.8M
Gross Margin
BAER
BAER
OCUL
OCUL
Q4 25
-65.1%
88.0%
Q3 25
68.9%
87.8%
Q2 25
39.2%
85.6%
Q1 25
-10.0%
88.2%
Q4 24
1.2%
92.8%
Q3 24
64.3%
89.9%
Q2 24
24.2%
90.8%
Q1 24
91.0%
Operating Margin
BAER
BAER
OCUL
OCUL
Q4 25
-175.0%
-526.5%
Q3 25
57.5%
-472.3%
Q2 25
18.0%
-502.6%
Q1 25
-64.9%
-597.5%
Q4 24
-48.0%
-296.1%
Q3 24
50.9%
-298.2%
Q2 24
-36.5%
-265.1%
Q1 24
-278.0%
-214.0%
Net Margin
BAER
BAER
OCUL
OCUL
Q4 25
-177.2%
-488.0%
Q3 25
50.8%
-477.3%
Q2 25
1.0%
-503.9%
Q1 25
-99.3%
-598.7%
Q4 24
-82.4%
-283.3%
Q3 24
42.4%
-236.6%
Q2 24
-76.7%
-266.3%
Q1 24
-364.8%
-438.9%
EPS (diluted)
BAER
BAER
OCUL
OCUL
Q4 25
$-0.26
$-0.27
Q3 25
$0.37
$-0.38
Q2 25
$-0.12
$-0.39
Q1 25
$-0.41
$-0.38
Q4 24
$-0.24
$-0.25
Q3 24
$0.31
$-0.22
Q2 24
$-0.33
$-0.26
Q1 24
$-0.55
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BAER
BAER
OCUL
OCUL
Cash + ST InvestmentsLiquidity on hand
$31.4M
$737.1M
Total DebtLower is stronger
$222.5M
Stockholders' EquityBook value
$-342.6M
$654.3M
Total Assets
$330.3M
$808.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BAER
BAER
OCUL
OCUL
Q4 25
$31.4M
$737.1M
Q3 25
$55.1M
$344.8M
Q2 25
$17.0M
$391.1M
Q1 25
$22.3M
$349.7M
Q4 24
$39.3M
$392.1M
Q3 24
$33.3M
$427.2M
Q2 24
$8.5M
$459.7M
Q1 24
$6.8M
$482.9M
Total Debt
BAER
BAER
OCUL
OCUL
Q4 25
$222.5M
Q3 25
Q2 25
Q1 25
Q4 24
$208.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
BAER
BAER
OCUL
OCUL
Q4 25
$-342.6M
$654.3M
Q3 25
$-322.4M
$258.2M
Q2 25
$-351.0M
$305.9M
Q1 25
$-347.4M
$265.9M
Q4 24
$-326.7M
$315.3M
Q3 24
$-304.4M
$352.0M
Q2 24
$-328.0M
$377.7M
Q1 24
$-348.7M
$408.0M
Total Assets
BAER
BAER
OCUL
OCUL
Q4 25
$330.3M
$808.1M
Q3 25
$311.0M
$410.9M
Q2 25
$279.0M
$451.3M
Q1 25
$275.6M
$405.9M
Q4 24
$290.8M
$457.9M
Q3 24
$307.3M
$490.4M
Q2 24
$281.7M
$517.1M
Q1 24
$252.4M
$538.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BAER
BAER
OCUL
OCUL
Operating Cash FlowLast quarter
$-8.0M
$-54.2M
Free Cash FlowOCF − Capex
$-78.4M
$-57.1M
FCF MarginFCF / Revenue
-917.3%
-430.9%
Capex IntensityCapex / Revenue
823.4%
21.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-64.2M
$-216.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BAER
BAER
OCUL
OCUL
Q4 25
$-8.0M
$-54.2M
Q3 25
$41.0M
$-50.7M
Q2 25
$1.4M
$-55.2M
Q1 25
$-17.7M
$-44.7M
Q4 24
$54.5M
$-39.4M
Q3 24
$200.0K
$-36.6M
Q2 24
$-22.6M
$-24.8M
Q1 24
$-22.8M
$-33.9M
Free Cash Flow
BAER
BAER
OCUL
OCUL
Q4 25
$-78.4M
$-57.1M
Q3 25
$34.6M
$-56.7M
Q2 25
$515.0K
$-56.5M
Q1 25
$-21.0M
$-46.6M
Q4 24
$53.5M
$-39.6M
Q3 24
$-951.0K
$-36.6M
Q2 24
$-23.6M
$-25.5M
Q1 24
$-23.7M
$-34.1M
FCF Margin
BAER
BAER
OCUL
OCUL
Q4 25
-917.3%
-430.9%
Q3 25
51.0%
-390.0%
Q2 25
1.7%
-419.7%
Q1 25
-134.0%
-435.6%
Q4 24
343.5%
-232.0%
Q3 24
-1.5%
-237.6%
Q2 24
-181.3%
-155.4%
Q1 24
-430.7%
-231.1%
Capex Intensity
BAER
BAER
OCUL
OCUL
Q4 25
823.4%
21.4%
Q3 25
9.3%
41.2%
Q2 25
3.0%
9.3%
Q1 25
21.2%
18.1%
Q4 24
6.3%
1.2%
Q3 24
1.8%
0.6%
Q2 24
7.6%
4.5%
Q1 24
17.4%
1.7%
Cash Conversion
BAER
BAER
OCUL
OCUL
Q4 25
Q3 25
1.19×
Q2 25
4.68×
Q1 25
Q4 24
Q3 24
0.01×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons